Filter By Industry
Filter By Tag

Newsroom

Mary Ann Liebert, Inc., publishers Press releases

101 - 110 of 131 Press Releases

Aug 29, 2012
Biomass recalcitrance can be overcome through improved methods of biomass characterization.

Aug 21, 2012
For the millions of people worldwide with type 1 diabetes who cannot produce sufficient insulin, the potential to transplant insulin-producing cells could offer hope for a long-term cure.

Aug 16, 2012
Every year tribal gaming generates billions of dollars in revenue, creates tens of thousands of jobs, and boosts the economies of many Native American communities.

Aug 13, 2012
Even after being frozen for 18 years, human embryos can be thawed, grown in the laboratory, and successfully induced to produce human embryonic stem (ES) cells, which represent a valuable resource for drug screening and medical research.

Aug 09, 2012
Despite criticism from Congressional Republicans and other groups, the U.S. Navy recently completed its Rim of the Pacific (RIMPAC) 2012 international maritime exercises, featuring the “Great Green Fleet” powered by a 50% biofuels blend.

Aug 07, 2012
The body’s natural reaction to reject replacement proteins represents a major obstacle to the successful use of gene therapy to cure a range of life-threatening diseases.

Aug 07, 2012
The global market value of Alzheimer's disease therapeutics could soar to the $8 billion range once therapeutics are approved that actually change the course of the disease, reports Genetic Engineering & Biotechnology News (GEN).

Aug 07, 2012
Genetic Engineering & Biotechnology News (GEN) has launched a unique microsite called Biotech Boulevard.

Jul 26, 2012
Administering high-doses of interleukin-2 (IL-2) has been the preferred treatment for patients with stage IV metastatic melanoma.

Jul 25, 2012
A novel approach to gene therapy that instructs a person’s own cells to produce more of a natural disease-fighting protein could offer a solution to treating many genetic disorders.


Page: Prev 9 10 11 12 13 Next
Mary Ann Liebert, Inc., publishers RSS Feed